Latest News
From the Journals
Low physical function tied to cardiac events in older adults
“We found that physical function in older adults predicts future cardiovascular disease beyond traditional heart disease risk factors, regardless...
Literature Review
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
FDA/CDC
Class I recall issued for intracranial pressure monitor
FDA is aware of at least 68 medical device reports (MDRs) associated with this problem.
From the Journals
Inhaled, systemic steroids linked to changes in brain structure
New research adds to the growing body of evidence suggesting that glucocorticoids have significant effects on the brain, which could explain their...
Conference Coverage
Majority of muscle symptoms with statins not caused by treatment
A new Cholesterol Trialists Collaboration meta-analysis shows that in 14 of the 15 people who experience muscle pain or weakness when taking a...
Feature
How do you live with COVID? One doctor’s personal experience
Early in 2020, Anne Peters, MD, caught COVID-19. The author of Medscape’s “Peters on Diabetes” column was sick in March 2020 before state-mandated...
Literature Review
Ublituximab bests teriflunomide in head-to-head clinical trials
The results of the ULTIMATE I and II trials may pave the way for ublituximab’s approval as the third high-efficacy anti-CD20 monoclonal antibody...
Latest News
Infographic: Is physician behavior on social media really so bad?
It’s not as egregious as you might think.
Conference Coverage
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart disease
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS...
Conference Coverage
COVID-19 vaccine safe in patients with heart failure
There should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF; moreover, vaccines provide a survival benefit...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...